Once-a-week pill for schizophrenia shows promise in clinical trials
The ingestible capsule forms a drug depot in the stomach, gradually releasing its payload and eliminating the need for patients to take medicine every day.
The ingestible capsule forms a drug depot in the stomach, gradually releasing its payload and eliminating the need for patients to take medicine every day.
Campus gathers with Vice President for Energy and Climate Evelyn Wang to explore the Climate Project at MIT, make connections, and exchange ideas.
Coactive, founded by two MIT alumni, has built an AI-powered platform to unlock new insights from content of all types.
Founded by two former regulars at the MITERS makerspace, the company has built huge, rugged drones to more safely and sustainably apply fertilizers and pesticides on farms.
A team of MIT researchers founded Themis AI to quantify AI model uncertainty and address knowledge gaps.
MIT’s Initiative for New Manufacturing extends a deep Institute legacy of expanding US growth and jobs through industrial production.
Allium Engineering, founded by two MIT alumni, has developed a process for improving steel rebar to triple the lifetime of bridges and other infrastructure.
The former US Army Helicopter pilot co-founded Helix Carbon to erase the carbon footprint of tough-to-decarbonize industries.
MIT course 15.362/6.9160 (Engineering Innovation: Global Security Systems) gives students an inside look at military problems and empowers them to build prototypes.
CoFlo Medical’s low-cost device could administer advanced biologic treatments more quickly to people with cancers, autoimmune diseases, and more.
Nona Technologies exemplifies how J-WAFS has helped launch real-world solutions for global water and food challenges.
Founded by former MIT Tata Center translational research director Jason Prapas, Fyto has built an automated system for harvesting the aquatic plant Lemna on dairy farms.
Moving Health has developed an emergency transportation network using motorized ambulances in rural regions of Ghana.
Founded by MIT researchers, Senti Bio is giving immune cells the ability to distinguish between healthy and cancerous cells.
CAMP4 Therapeutics is targeting regulatory RNA, whose role in gene expression was first described by co-founder and MIT Professor Richard Young.